Hidradenitis suppurativa in transgender and gender diverse patients: A retrospective review with examination of the role of hormone therapy

Reese L Imhof; Austin Todd; Caroline J Davidge-Pitts; Afsaneh Alavi

doi:10.1016/j.jaad.2023.12.009

Hidradenitis suppurativa in transgender and gender diverse patients: A retrospective review with examination of the role of hormone therapy

J Am Acad Dermatol. 2024 Apr;90(4):845-847. doi: 10.1016/j.jaad.2023.12.009. Epub 2023 Dec 10.

Authors

Reese L Imhof¹, Austin Todd², Caroline J Davidge-Pitts³, Afsaneh Alavi⁴

Affiliations

¹ Department of Dermatology, Mayo Clinic, Rochester, Minnesota. Electronic address: Imhof.Reese@mayo.edu.
² Department of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota.
³ Department of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, Minnesota.
⁴ Department of Dermatology, Mayo Clinic, Rochester, Minnesota.

PMID: 38086516
DOI: 10.1016/j.jaad.2023.12.009

No abstract available

Keywords: androgens; endocrinology; estrogens; gender diverse; gender minority; hidradenitis; hidradenitis suppurativa; hormone therapy; transgender.

MeSH terms

Hidradenitis Suppurativa* / diagnosis
Hormones
Humans
Retrospective Studies
Transgender Persons*
Transsexualism*

Substances

Hormones